Neurotech Reports

As we enter our 25th year publishing Neurotech Business Report, we will periodically post here some previously published content that we think has made an impact on the industry. We'll begin with our very first publisher's letter from Volume 1, Number 1, September 2001. If you repost this, we'll send you the full issue. https://lnkd.in/gbcCbZeB

We're pleased to announce our first European conference, the Neurotech Leaders Forum at imec, to be held June 3-4, 2025 at imec headquarters in Leuven, Belgium. View the agenda here: https://lnkd.in/g6vkukTt

We're pleased to report that Lisa Shafer, vice president of product development at Biogen, will keynote the 2025 Bioelectronic Medicine Forum, April 10 at The New York Academy of Medicine in Manhattan. She has held executive management positions at key pharmaceutical firms such as Teva as well as neurotech firms such as?Medtronic. In her distinguished career, she has helped bridge the gap between device and drug therapies as a chief scientific officer and product development executive. We're still recruiting speakers, sponsors, and presenters for the 8th annual conference so sign up now to participate. https://lnkd.in/gyv4mha

While last-minute voters are deciding who will get their votes tomorrow, Neurotech Reports editors are voting on the winners of the 2024 Gold Electrode Awards, which will be announced at the 2024 Neurotech Leaders Forum in San Francisco this week. You need not be present to win, but it's more fun if you're there to accept your award in person! https://lnkd.in/gR_wH549

Erika Petersen from UAMS - University of Arkansas for Medical Sciences offers unique metaphor for closed-loop neuromodulation during Saluda Medical event. She compares it to a radio station that measures audience response to broadcast signals. Not sufficient to just look at transmission power.

Warren Grill from Duke University explains his team's model of wide dynamic range neuron response in dorsal column during International Neuromodulation Society meeting in Vancouver. Striking correspondence between model and experimental data. Surround inhibition plays a key role.

Lawrence Poree addresses neuromodulation for pain and opioid use disorder. "It's not pain until it gets to the brain," he rhymed.

The market for peripheral nerve stimulation continues to grow as new vendors and new technological approaches emerge. DM us if you would like to receive a copy of Jeremy Koff’s recent article in Neurotech Business Report surveying the landscape. Also, we are looking for implanters to participate in a brief confidential survey regarding PNS therapies. If you are a pain doctor or other clinician with experience implanting PNS systems, we can offer you a free subscription to Neurotech Business Report ($895 value). Message us if interested.